Pfm Health Sciences, LP Zai Lab LTD Transaction History

Pfm Health Sciences, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$25.3 - $39.67 $6.24 Million - $9.79 Million	246,706 New	246,706 $6.84 Million
Q3 2022 Nov 14, 2022	BUY	$34.2 - $51.69 $807,530 - $1.22 Million	23,612 New	23,612 $808,000
Q4 2021 Feb 14, 2022	SELL	$54.9 - $105.21 $5.46 Million - $10.5 Million	-99,375 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$126.27 - $191.71 $970,511 - $1.47 Million	-7,686 Reduced 7.18%	99,375 $13.3 Million
Q4 2020 Feb 16, 2021	BUY	$81.94 - $135.34 $8.77 Million - $14.5 Million	107,061 New	107,061 $14.5 Million
Q2 2020 Aug 14, 2020	SELL	$48.82 - $82.53 $4.12 Million - $6.96 Million	-84,387 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$39.1 - $62.9 $3.3 Million - $5.31 Million	84,387 New	84,387 $4.34 Million
Q2 2019 Aug 14, 2019	SELL	$25.73 - $35.79 $4.05 Million - $5.63 Million	-157,442 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$21.71 - $31.54 $3.42 Million - $4.97 Million	157,442 New	157,442 $4.65 Million

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.59B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

Stay updated on Pfm Health Sciences, LP with notifications on news.